Moderna’s mRNA-1273 Vaccine Put to Biggest Test
The experimental vaccine, mRNA-1273, is put to its biggest test as 30,000 American volunteers roll...
Read More
FDA / Research
Moderna’s Pipeline Beyond COVID-19 and mRNA 1273
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA)...
Read More
Covid-19: As Moderna Heads to Phase III Trial, Vaccine Shows Robust Results in Primates
Vaccine maker gets $472 million booster shot Moderna announced that it is moving into phase III...
Read More
The Color of COVID: Will Vaccine Trials Reflect America’s Diversity?
Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they’ve historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
Read More
Covid-19: Another Fail for Hydroxychloroquine
The drug, either alone or in combination with azithromycin, failed to improve outcomes for...
Read More
COVID-19 Pandemic Has Had Impact on Parent, Child Well-Being
FRIDAY, July 24, 2020 (HealthDay News) — The COVID-19 pandemic has had a considerable impact...
Read More
Heart Transplant Volumes Decreased in COVID-19 Era
FRIDAY, July 24, 2020 (HealthDay News) — In the COVID-19 era, there has been a decrease in...
Read More
Mental Health Deteriorated During COVID-19 Lockdown
FRIDAY, July 24, 2020 (HealthDay News) — Mental health deteriorated in the United Kingdom by...
Read More
High Prevalence of Americans Have Conditions Linked to Severe COVID-19
THURSDAY, July 23, 2020 (HealthDay News) — The median prevalence of any underlying medical...
Read More
Role of COVID-19 Treatments Explored in Patients With Cancer
THURSDAY, July 23, 2020 (HealthDay News) — For adults with invasive cancer and severe acute...
Read More
Ad5-Vectored COVID-19 Vaccine Immunogenic in Healthy Adults
THURSDAY, July 23, 2020 (HealthDay News) — The nonreplicating adenovirus type-5...
Read More
Scientists Want to Know More About Using UV Light to Fight COVID-19 Spread
‘Germicidal’ ultraviolet light technology has a proven track record against indoor transmission of tuberculosis and other airborne microbes. It’s now being used in some restaurants and on subways.
Read More
Covid 19: For Testing, Francis S. Collins Has a Plan
NIH is pulling out all stops with its RADx national testing program As director of the National...
Read More
NIH Project Hones In on COVID Racial Disparities
The pandemic has given the National Institutes of Health an opportunity to show the value of its $1.5 billion “All of Us” research program. A major effort to make the platform’s database representative of America resulted in minorities making up more than half of its more than 270,000 volunteers.
Read More
Covid-19: Early, Promising Results for Three Vaccines
Phase II trials from AstraZeneca, CanSino, and Pfizer poised to move on to phase III As the...
Read More
Covid-19: Virus Detected in Donor’s Blood Weeks After Recovery
Case raises safety concerns about blood supply A case of detectable SARS-CoV-2 in a volunteer...
Read More
Why Doctors Keep Monitoring Kids Who Recover From Mysterious COVID-Linked Illness
About 1,000 children worldwide have had the condition known as MIS-C — Multisymptom Inflammatory Syndrome in Children. Children’s hospitals around the U.S. are trying to keep tabs on young people after they recover from the ailment, to gauge any long-term effects.
Read More
Variety of Symptoms Reported for COVID-19 Patients
FRIDAY, July 17, 2020 (HealthDay News) — Nearly all symptomatic COVID-19 patients experience...
Read More
Lopinavir/Ritonavir COVID-19 Treatment Linked to Bradycardia
FRIDAY, July 17, 2020 (HealthDay News) — Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19...
Read More
Call for ‘Challenge Trials’ to Hasten COVID-19 Vaccine Development
FRIDAY, July 17, 2020 (HealthDay News) — The U.S. government should make immediate...
Read More